Back

Impact of aortic valve calcium score on prognosis and treatment outcomes in LFLG aortic stenosis

18 May 2025 (12:25 - 13:34)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular heart disease (2) Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mariana Caetano Coelho

Hospital de Santa Marta, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Impact of left ventricular volume and effective regurgitant orifice area on mortality effects of transcatheter edge-to-edge mitral valve repair: a meta-regression analysis
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of cardiac computed tomography parameters to predict pre-intervention outcomes in patients with severe aortic stenosis
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Ballon vs self-expandable valves : pacemaker implantation analysis
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of device performance and pacemaker implantation rates in supra-Annular and intra-annular TAVR valves in patients with small aortic annulus
Doctor M. Caetano Coelho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
A comparison of self-expanding and balloon-expandable valves in pacemaker implantation rates in TAVI
Doctor M. Caetano Coelho (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular heart disease (2)

The Event

Event poster

Heart Failure 2025

18 May 2025 12:25 CET
You may be interested in
thumbnail
Congress Presentation
Multimodality approach to low-flow, low-gradient aortic stenosis: sex-specific ct calcium thresholds validated by dobutamine stress echocardiography
thumbnail
Congress Presentation
Dobutamine stress echocardiography remains indispensable for the diagnosis of low-flow low-gradient severe aortic stenosis
thumbnail
Congress Presentation
Risk assessment in patients with low-flow, low-gradient aortic stenosis undergoing TAVI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources